首页>
外国专利>
Procedure for the production of New Derivatives of 2 - (3 - alquilcarbamoilfenil) - 6 - alquilcarbamoil - 4 - (3H) - quinazolonas as well as 2 - (3 - alquilcarbamoilfenil) - 6 - alquilcarbamoil - 4 - (3H) - quinazolonas
Procedure for the production of New Derivatives of 2 - (3 - alquilcarbamoilfenil) - 6 - alquilcarbamoil - 4 - (3H) - quinazolonas as well as 2 - (3 - alquilcarbamoilfenil) - 6 - alquilcarbamoil - 4 - (3H) - quinazolonas
1333284 Quinazoline derived biscarbamates BAYER AG 11 Oct 1971 [13 Oct 1970] 47212/71 Heading C2C The invention comprises compounds of formula wherein X is O or S, R is alkyl (optionally with its C chain interrupted by O or S), cycloalkyl, aralkyl or aryl, RSP1/SP is alkyl, cycloalkyl or Ph, and any hydrocarbon radicals mentioned may be substituted. In examples, these compounds are prepared by reacting (1) the corresponding diisocyanate or diisothiocyanate with ROH, or (2) the corresponding diamine with ClCO 2 R, or (to obtain a product where R is 2-hydroxyethyl) glycol carbonate. Therapeutic compositions having cytostatic activity comprise compounds of the above formula, and may be administered orally, parenterally or rectally.
展开▼
机译:1333284喹唑啉衍生的双氨基甲酸酯BAYER AG 1971年10月11日[1970年10月13日] C2C标题本发明包括式X的化合物,其中X为O或S,R为烷基(可选地,其C链被O或S中断),环烷基,芳烷基或芳基,R SP 1是烷基,环烷基或Ph,并且任何提及的烃基可以被取代。在实施例中,这些化合物是通过使(1)相应的二异氰酸酯或二异硫氰酸酯与ROH反应,或(2)相应的二胺与ClCO 2 R反应,或(获得R为2-羟乙基的产物)碳酸乙二醇酯来制备的。具有细胞抑制活性的治疗组合物包含上式的化合物,并且可以口服,肠胃外或直肠给药。
展开▼